Synapse Open Synapse
Biology

UK Sovereign AI grant helps fund immune profiling of 80,000 UK Biobank blood samples

R&D World · · 1 min read

IMU Biosciences, a London-based biotechnology company specializing in immune profiling and AI analysis, and UK Biobank, a research resource tracking the health of 500,000 participants, will profile immune cells in 80,000 blood samples to investigate how differences in the immune system relate to disease.

Latest from R&D World